109 related articles for article (PubMed ID: 11399124)
1. Cancer genesis: stem tumour cells as an MHC-null/HSP70 - very high 'primordial self' escaping both MHC-restricted and MHC-non- restricted immunesurveillance.
Manzo G
Med Hypotheses; 2001 Jun; 56(6):724-30. PubMed ID: 11399124
[TBL] [Abstract][Full Text] [Related]
2. The cancer process as a type of immunocomplex hypersensibility involving C3b, natural killer cytotoxicity and antibody-dependent cell cytotoxicity: proposals for tumour immunotherapy and vaccine.
Manzo G
Med Hypotheses; 1998 May; 50(5):409-13. PubMed ID: 9681920
[TBL] [Abstract][Full Text] [Related]
3. Tumour MHC class I downregulation and immunotherapy (Review).
Bubeník J
Oncol Rep; 2003; 10(6):2005-8. PubMed ID: 14534734
[TBL] [Abstract][Full Text] [Related]
4. MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Cho JA; Lee YS; Kim SH; Ko JK; Kim CW
Cancer Lett; 2009 Mar; 275(2):256-65. PubMed ID: 19036499
[TBL] [Abstract][Full Text] [Related]
5. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory functions of membrane-bound and exported heat shock protein 70.
Radons J; Multhoff G
Exerc Immunol Rev; 2005; 11():17-33. PubMed ID: 16385841
[TBL] [Abstract][Full Text] [Related]
7. MHC class I down-regulation: tumour escape from immune surveillance? (review).
Bubeník J
Int J Oncol; 2004 Aug; 25(2):487-91. PubMed ID: 15254748
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein 70: role in antigen presentation and immune stimulation.
Milani V; Noessner E; Ghose S; Kuppner M; Ahrens B; Scharner A; Gastpar R; Issels RD
Int J Hyperthermia; 2002; 18(6):563-75. PubMed ID: 12537755
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of cancer through targeting of minor histocompatibility antigens.
Hambach L; Goulmy E
Curr Opin Immunol; 2005 Apr; 17(2):202-10. PubMed ID: 15766682
[TBL] [Abstract][Full Text] [Related]
10. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity.
Calderwood SK; Theriault JR; Gong J
Eur J Immunol; 2005 Sep; 35(9):2518-27. PubMed ID: 16144035
[TBL] [Abstract][Full Text] [Related]
11. Immunological correlations between ontogenesis and oncogenesis: theoretical implications and suggestions for tumor immunotherapy.
Manzo G
Med Hypotheses; 1992 Mar; 37(3):166-70. PubMed ID: 1584106
[TBL] [Abstract][Full Text] [Related]
12. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.
Ruggeri L; Mancusi A; Capanni M; Martelli MF; Velardi A
Curr Opin Immunol; 2005 Apr; 17(2):211-7. PubMed ID: 15766683
[TBL] [Abstract][Full Text] [Related]
13. Modified HPV16 E7/HSP70 DNA vaccine with high safety and enhanced cellular immunity represses murine lung metastatic tumors with downregulated expression of MHC class I molecules.
Li H; Ou X; Xiong J
Gynecol Oncol; 2007 Mar; 104(3):564-71. PubMed ID: 17081598
[TBL] [Abstract][Full Text] [Related]
14. MHC expression in a human adult stem cell line and its down-regulation by hCMV US gene transfection.
Kim JY; Kim D; Choi I; Yang JS; Lee DS; Lee JR; Kang K; Kim S; Hwang WS; Lee JS; Ahn C
Int J Biochem Cell Biol; 2005 Jan; 37(1):69-78. PubMed ID: 15381151
[TBL] [Abstract][Full Text] [Related]
15. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
16. Current concepts in immunotherapy for the treatment of colorectal cancer.
Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells directed toward the widely expressed tumor T-cell epitopes of the telomerase catalytic subunit.
Lev A; Denkberg G; Cohen CJ; Tzukerman M; Skorecki KL; Chames P; Hoogenboom HR; Reiter Y
Cancer Res; 2002 Jun; 62(11):3184-94. PubMed ID: 12036932
[TBL] [Abstract][Full Text] [Related]
18. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.
Li Y; Subjeck J; Yang G; Repasky E; Wang XY
Vaccine; 2006 Jun; 24(25):5360-70. PubMed ID: 16714072
[TBL] [Abstract][Full Text] [Related]
19. Direct detection and quantitation of a distinct T-cell epitope derived from tumor-specific epithelial cell-associated mucin using human recombinant antibodies endowed with the antigen-specific, major histocompatibility complex-restricted specificity of T cells.
Cohen CJ; Hoffmann N; Farago M; Hoogenboom HR; Eisenbach L; Reiter Y
Cancer Res; 2002 Oct; 62(20):5835-44. PubMed ID: 12384546
[TBL] [Abstract][Full Text] [Related]
20. The 70 kilodalton heat shock protein is an inhibitor of apoptosis in prostate cancer.
Jones EL; Zhao MJ; Stevenson MA; Calderwood SK
Int J Hyperthermia; 2004 Dec; 20(8):835-49. PubMed ID: 15764345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
